AmpliPhi Biosciences Corp Business Finance Contracts & Agreements
64 Contracts & Agreements
- Credit Agreements (8 contracts)
- Exchange Agreements (4)
- Funding Agreements (3)
- Investor Rights Agreements (4)
- Note Agreements (1)
- Purchase Agreements (8)
- Registration Rights Agreements (8)
- Share Agreements (1)
- Stock Agreements (4)
- Subscription Agreements (1)
- Underwriting Agreements (4)
- Warrant Agreements (18)
- Third Amendment to Secured Convertible Credit and Security Agreement, dated as of November 12, 2024, by and among the Issuer, Innoviva Sub and the other parties thereto (Filed With SEC on November 15, 2024)
- Second Amendment to Credit and Security Agreement, dated as of November 12, 2024, by and among the Issuer, Innoviva Sub and the other parties thereto (Filed With SEC on November 15, 2024)
- Second Amendment to Convertible Credit and Security Agreement (Filed With SEC on March 4, 2024)
- First Amendment to Credit and Security Agreement (Filed With SEC on March 4, 2024)
- Credit and Security Agreement, dated March 4, 2024 (Filed With SEC on March 4, 2024)
- First Amendment to Secured Convertible Credit and Security Agreement (Filed With SEC on July 11, 2023)
- Credit and Security Agreement, dated July 10, 2023 (Filed With SEC on July 11, 2023)
- Secured Convertible Credit and Security Agreement, dated January 10, 2023 (Filed With SEC on January 10, 2023)
- Registration Rights Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)
- Second Amended and Restated Investors Rights Agreement, dated February 9, 2022, by and among the Company, Innoviva, Inc. and Innoviva (Filed With SEC on February 11, 2022)
- Securities Purchase Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)
- Form of Common Stock Warrant (Filed With SEC on February 11, 2022)
- Registration Rights Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)
- Securities Purchase Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)
- Form of Registration Rights Agreement, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)
- Form of Amended and Restated Investors Rights Agreement, by and among the Company and Innoviva (Filed With SEC on January 27, 2021)
- Securities Purchase Agreement, dated January 26, 2021, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)
- Form of Common Stock Warrant (Filed With SEC on January 27, 2021)
- Investor Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)
- Registration Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)
- Form of Investor Rights Agreement, by and the Company and Innoviva (Filed With SEC on January 29, 2020)
- Securities Purchase Agreement, dated January 27, 2020, by and between the Company and Innoviva (Filed With SEC on January 29, 2020)
- Form of Common Stock Warrant (Filed With SEC on January 29, 2020)
- Asset Purchase Agreement, dated as of February 14, 2018, by and between C3J Therapeutics, Inc., Synthetic Genomics, Inc. and Synthetic Genomics Vaccines, Inc., as amended by... (Filed With SEC on August 14, 2019)
- Armata Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan (Filed With SEC on August 14, 2019)
- Registration Rights Agreement, dated as of May 9, 2019, by and among Armata Pharmaceuticals, Inc. and the Investors (Filed With SEC on May 10, 2019)
- Form of the Armata Pharmaceuticals, Inc. Common Stock Certificate (Filed With SEC on May 10, 2019)
- Form of Share Purchase Agreement by and among AmpliPhi Biosciences Corporation, C3J Therapeutics, Inc. and certain shareholders of C3J Therapeutics, Inc., dated as of February 5,... (Filed With SEC on February 7, 2019)
- Form of Warrant to Purchase Common Stock (Filed With SEC on October 9, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on October 9, 2018)
- Form of Underwriting Agreement (Filed With SEC on October 9, 2018)
- Form of Pre-Funded Warrant (Filed With SEC on September 18, 2018)
- Form of Underwriting Agreement (Filed With SEC on September 18, 2018)
- PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on May 1, 2017)
- COMMON STOCK PURCHASE WARRANT AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on May 1, 2017)
- [ ] Shares of Common Stock Pre-Funded Warrants to Purchase [ ]Shares of Common Stock and Warrants to Purchase [ ] Shares of CommonStock AMPLIPHI BIOSCIENCES CORPORATION... (Filed With SEC on May 1, 2017)
- COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 17, 2016)
- COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 16, 2016)
- COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 10, 2016)
- AMPLIPHI BIOSCIENCES CORPORATION WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 14, 2016)
